Cargando…

Why do we not have a cure for rheumatoid arthritis?

CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Y...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Gabalawy, Hani D, Lipsky, Peter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240144/
https://www.ncbi.nlm.nih.gov/pubmed/12110149
http://dx.doi.org/10.1186/ar568
_version_ 1782219347783057408
author El-Gabalawy, Hani D
Lipsky, Peter E
author_facet El-Gabalawy, Hani D
Lipsky, Peter E
author_sort El-Gabalawy, Hani D
collection PubMed
description CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research.
format Online
Article
Text
id pubmed-3240144
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32401442011-12-16 Why do we not have a cure for rheumatoid arthritis? El-Gabalawy, Hani D Lipsky, Peter E Arthritis Res Review CHAPTER SUMMARY: There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research. BioMed Central 2002 2002-05-09 /pmc/articles/PMC3240144/ /pubmed/12110149 http://dx.doi.org/10.1186/ar568 Text en Copyright ©2002 BioMed Central Ltd
spellingShingle Review
El-Gabalawy, Hani D
Lipsky, Peter E
Why do we not have a cure for rheumatoid arthritis?
title Why do we not have a cure for rheumatoid arthritis?
title_full Why do we not have a cure for rheumatoid arthritis?
title_fullStr Why do we not have a cure for rheumatoid arthritis?
title_full_unstemmed Why do we not have a cure for rheumatoid arthritis?
title_short Why do we not have a cure for rheumatoid arthritis?
title_sort why do we not have a cure for rheumatoid arthritis?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240144/
https://www.ncbi.nlm.nih.gov/pubmed/12110149
http://dx.doi.org/10.1186/ar568
work_keys_str_mv AT elgabalawyhanid whydowenothaveacureforrheumatoidarthritis
AT lipskypetere whydowenothaveacureforrheumatoidarthritis